文献速递疼痛医学区域麻醉与超声

超声引导下C2水平枕大神经阻滞的临床疗效

Clinical Efficacy of an Ultrasound-Guided Greater Occipital Nerve Block at the Level of C2.
PubMed 文献 · Reg Anesth Pain Med · 2017-01-01

这项前瞻性开放标签研究纳入枕神经痛或颈源性头痛患者,由经验丰富的临床医生按标准化方案在C2水平行超声引导下枕大神经阻滞。共完成14次注射,平均操作时间3.75分钟,注射后30分钟86%的患者出现枕大神经分布区麻醉,疼痛评分在30分钟、2周和4周均较基线显著下降,研究期间未报告显著不良事件。

要点

  • C2水平超声引导枕大神经阻滞平均操作时间3.75分钟,30分钟时86%患者达分布区麻醉。
  • 疼痛评分较基线平均下降3.78(30分钟,P<0.001)、2.64(2周,P=0.006)、2.21(4周,P=0.01)。
  • 研究期间未报告显著不良事件,结果为后续随机试验提供初步数据。

核心结论

  • 该前瞻性开放标签研究显示,采用新型超声引导技术在C2水平成功阻滞枕大神经,4周研究期内疼痛评分显著下降且未报告不良事件。

研究设计与样本

  • 前瞻性开放标签研究,纳入诊断为枕神经痛或颈源性头痛的患者,由经验丰富的临床医生按标准化方案行超声引导下C2水平枕大神经阻滞,共完成14次注射。

主要发现

  • 平均操作时间为3.75分钟。
  • 注射后30分钟86%的患者出现枕大神经分布区麻醉。
  • 数字评分量表疼痛评分较基线平均下降3.78(30分钟,P<0.001)、2.64(2周,P=0.006)、2.21(4周,P=0.01)。
  • 研究期间未报告显著不良事件。

临床怎么用

  • 对于枕神经痛或颈源性头痛患者,可考虑采用超声引导下C2水平枕大神经阻滞,操作时间较短且本研究中未报告显著不良事件。

局限性

  • 本研究为前瞻性开放标签设计,样本量小(共14次注射),结果需未来随机试验进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The purpose of this prospective open-label study was to investigate the analgesic effects of an ultrasound-guided greater occipital nerve (GON) block at the level of C2, as the nerve courses superficially to the obliquus capitis inferior muscle. METHODS: Patients with a diagnosis of occipital neuralgia or cervicogenic headache were recruited for the study. Ultrasound-guided GON blocks at the level of C2 were performed by experienced clinicians according to a standardized protocol. Numeric rating scale pain scores were recorded preinjection and at 30 minutes, 2 weeks, and 4 weeks after injection. RESULTS: A total of 14 injections were performed with a mean procedure time of 3.75 minutes. Anesthesia in the GON distribution was achieved for 86% of patients at 30 minutes postinjection. Compared with baseline, numeric rating scale scores decreased by a mean of 3.78 at 30 minutes (P < 0.001), 2.64 at 2 weeks (P = 0.006), and 2.21 at 4 weeks (P = 0.01). There were no significant adverse events reported during the study period. CONCLUSIONS: This prospective open-label study demonstrated successful blockade of the GON at the level of C2 using a novel ultrasound-guided technique. Significant reductions in pain scores were observed over the 4-week study period, and no adverse events were reported. The observations from this study provide important preliminary data for future randomized trials involving patients with occipital neuralgia and cervicogenic headache.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Pingree MJ, Sole JS, Oʼ Brien TG, et al. Clinical Efficacy of an Ultrasound-Guided Greater Occipital Nerve Block at the Level of C2. Reg Anesth Pain Med. 2017. PMID: 27811528. doi:10.1097/AAP.0000000000000513

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。